Personalized CRISPR Therapy Brings Hope to Families

Quick Smiles:

• Groundbreaking CRISPR therapy developed for baby’s rare genetic disorder
• KJ receives three safe, effective treatments and is thriving
• Custom therapies offer new possibilities for other families

Doctors at Children’s Hospital of Philadelphia created a one-of-a-kind CRISPR gene therapy for baby KJ, born with a rare metabolic disorder that made it impossible for him to safely process ammonia in his body.

KJ’s parents entrusted his care to Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru, leading researchers who developed a personalized treatment that corrected the faulty gene responsible for his condition.

“Years and years of progress in gene editing and collaboration between researchers and clinicians made this moment possible, and while KJ is just one patient, we hope he is the first of many to benefit from a methodology that can be scaled to fit an individual patient’s needs,” said Dr. Ahrens-Nicklas.

This experimental therapy was specifically designed for KJ’s unique gene variant and delivered in three doses, resulting in no side effects and allowing him to stop medication and enjoy a more nourishing diet.

KJ’s story is paving the way for custom CRISPR treatments, inspiring hope for families facing rare genetic challenges.

“We thought it was our responsibility to help our child, so when the doctors came to us with their idea, we put our trust in them in the hopes that it could help not just KJ but other families in our position,” said KJ’s mother, Nicole.

This remarkable advancement shows what can happen when dedicated scientists, compassionate doctors, and hopeful families work together. Stay tuned for more heartening updates on medical breakthroughs!

Source